Compare DNA & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNA | FEIM |
|---|---|---|
| Founded | 2008 | 1961 |
| Country | United States | United States |
| Employees | 485 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 439.6M |
| IPO Year | N/A | 1994 |
| Metric | DNA | FEIM |
|---|---|---|
| Price | $6.45 | $54.80 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $8.50 | ★ $42.50 |
| AVG Volume (30 Days) | ★ 1.2M | 225.4K |
| Earning Date | 05-05-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 316.95 |
| EPS | N/A | ★ 0.41 |
| Revenue | N/A | ★ $69,811,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $21.73 |
| P/E Ratio | ★ N/A | $127.73 |
| Revenue Growth | N/A | ★ 26.30 |
| 52 Week Low | $5.37 | $16.50 |
| 52 Week High | $17.58 | $61.47 |
| Indicator | DNA | FEIM |
|---|---|---|
| Relative Strength Index (RSI) | 44.20 | 58.06 |
| Support Level | $6.26 | $49.46 |
| Resistance Level | $7.38 | $59.68 |
| Average True Range (ATR) | 0.53 | 4.02 |
| MACD | 0.08 | 1.31 |
| Stochastic Oscillator | 46.88 | 74.93 |
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.